Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Humoral Chronic Rejection After Renal Transplantation
NCT00568477Phase 2Terminated
- Sponsor
- Technical University of Munich
- Start
- Dec 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in Chronic Allograft Kidney Disease (CKaD), sponsored by Technical University of Munich. Started Dec 2007; status: terminated.
02
Drugs
rituximab
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on NCT00568477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568477.